XRF Scientific Limited (ASX:XRF)

Market Cap	296.09M -4.6%
Revenue (ttm)	64.40M +8.3%
Net Income	10.49M +1.0%
EPS	0.07 -1.4%
Shares Out	143.04M
PE Ratio	28.36
Forward PE	23.00
Dividend	0.05 (2.17%)
Ex-Dividend Date	Sep 10, 2026

Volume	148,112
Open	2.090
Previous Close	2.080
Day's Range	2.050 - 2.090
52-Week Range	1.600 - 2.260
Beta	0.65
Analysts	Strong Buy
Price Target	2.31 (+11.59%)
Est. Earnings	Nov 17, 2026

About XRF Scientific

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets....

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1972
• Employees: 48
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: XRF

Financial Performance

In fiscal year 2026, XRF Scientific's revenue was 64.40 million, an increase of 8.33% compared to the previous year's 59.45 million. Earnings were 10.49 million, an increase of 1.01%.

Analyst Summary

According to 2 analysts, the average rating for XRF stock is "Strong Buy." The 12-month stock price target is $2.31, which is an increase of 11.59% from the latest price.

Price Target

$2.31

(11.59% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 4, 2026

Data Sources Report a data error